News

“I'm delighted to announce the outstanding results of Omega’s successful flow test of our Canyon-1H well. While we were anticipating commercial flow rates of a large-scale gas play, we have ...
Aspire Biopharma (ASBP) announced initiation of its Phase 1 single- center clinical study of its lead therapeutic candidate, an oral transmucosal fast-acting high-dose aspirin formulation.
Paracetamol, aspirin and ibuprofen are among the most widely used. While they are all effective for pain relief, they each work in a slightly different way and ideally, tackling different symptoms.
Aspire Biopharma Holdings, Inc, a developer of a multi-faceted patent-pending drug delivery technology, announced initiation of its phase 1 single-centre clinical study of its lead therapeutic ...
Nuclear magnetic resonance (NMR) spectroscopy is a technique that detects the chemical environment of atomic nuclei by the absorption of radio-frequency electromagnetic radiation when in the ...
Fashion giant H&M plans to create digital clones of its models this year, raising more questions for an industry grappling with both the potential of artificial intelligence (AI) and its impact on ...
Confirmed moon sighting sets Eid Al Fitr on March 31 in the Philippines Manila: The Philippines has officially announced that Eid Al Fitr will be observed on Monday, March 31, 2025, following the ...
U.S. Vice President JD Vance has announced that a green card does not guarantee indefinite stay, heightening anxiety among Indian immigrants. Enhanced checks at entry points, visa stamping delays ...
Trial designed to evaluate safety, pharmacokinetics and pharmacodynamics, of Aspire's sublingual aspirin product Aspire anticipates releasing initial clinical data from trial at the end of the ...
Now, if the number of registrations exceeds the annual cap, US Citizenship and Immigration Services (USCIS) will do a lottery to randomly select recipients. The results of the lottery are ...